Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't pump or bash anything. Just objectively citing the facts.
Don't blame me for MK continually crapping on his own stock. I'm just citing the facts per his own updates, and the facts aren't pretty. They are what they are.
If this was a manageable multitask situation, Radiogel would have been in human trials years ago. MK has been in charge 8 years and wasted 5 of those years before even talking to FDA about Radiogel human trials in 2021. Then he wasted most of last 3 years resisting FDA suggestions at every turn. Hence why here we are in 2024, and MK has yet to submit a single item FDA suggested years ago. Why? Because IsoPet is his highest priority per his updates and Radiogel is his lowest priority.
IsoPet was launched 5 years ago, has never been even close to profitable and there is no plausible scenario of it becoming profitable before cash well runs dry. Yet MK continues to peddle it, clearly at the expense of getting Radiogel to human trials.
Lastly, there is no data from the IsoPet business. Anecdotes of uncontrolled and unmonitored one off pet treatments, are just that, anecdotes. An anecdote is not the singular of data. Useful Data for FDA to consider Radiogel for human trials has to be controlled and monitored, like the alleged completed rabbit data that MK has lied in the past about completing and has failed to date to submit to FDA.
amen
And we already know per RDGL updates since that MK's Dec. 20, 2023 claim of Radiogel BDD status is having no impact on getting Radiogel to human trials. Ball remains in RDGL's court to get FDA what has already been agreed to going back years now. To date, MK hasn't delivered any of those items. It is what it is.
All facts per MK's own updates. It is what it is.
Please, all those news reports cited RDGL as source for BDD claim. I've seen no independent corroboration from any reputable source like FDA. MK is a confirmed serial liar about many things going back years. RDGL isn't a reputable source for anything as long as MK remains at helm. In any case, we now know BDD status has no impact on getting Radiogel to human trials.
Per his own updates, he has yet to submit anything FDA has suggested since 2021, including the rabbit results that have yet to go through third party review. He did lie several times in 2023 that rabbit testing had favorably concluded and results were being written up, but then later revealed, no testing remained ongoing. Now he claims same, that testing has concluded and results are being written up. There's been no confirmation to date he's submitted the write up for third party review yet, let alone that results have been submitted to FDA.
And why were years lost before MK commenced controlled animal testing? Because he wasted 2 years resisting FDA suggestion for controlled data. It's all there in the updates for anyone to read.
And why wasn't the genotoxicity issue put to bed years ago? Because MK waited over a year to respond to FDA comments from first meeting in 2021 and then wasted many months resisting that suggestion too when they were dissatisfied with some of his responses. Again, it's all there for anyone to read.
Just citing the facts. Are you claiming FDA will approve Radiogel human trials without RDGL even asking them to do so?
FDA can only consider what is submitted and RDGL has to submit an IDE application for human trials with the data FDA has suggested since 2021 for FDA to consider. Once submitted, the consideration period is 30 days. FDA may then approve human trials, conditionally approve with a list of items that must be completed to FDA satisfaction beforehand, or they may outright reject the application.
To date, per his own updates, MK has failed to submit any of that data FDA suggested, let alone submit the completed IDE application.
All facts.
I have. 1st, MK is a proven serial liar, and there's been no corroboration of the claimed BDD status from any reputable source. 2nd, we have learned from RDGL since MK's Dec. 20 BDD failed pump that RDGL still has to submit all data FDA suggested previously to complete an IDE application, and to date, MK hasn't submitted anything, not a single item. Conclusion: claimed BDD status is having no impact on getting Radiogel to human trials. The bottleneck is 100% on RDGL to submit an IDE application.
It is what it is.
Doesn't matter when IsoPet is sold at a loss. It's a hopeless distraction.
Gotta keep it real.
The consideration period for IDE application is 30 days. That's as expedited as it gets. BDD status, even if true, doesn't speed that. Burden remains with MK to deliver the IDE application. BDD status doesn't expedite that either, as FDA can't submit the application for RDGL.
So even if MK is lying about BDD status, it has no impact on speed of getting Radiogel to human trials. Sadly, MK has made very clear this is his lowest priority.
Please, he's the CEO. He is responsible for what's posted. If he didn't post it himself, he condones the Tweet, or it would/will be taken down. Time will tell.
Point is, like the Feb. downdate, today's Tweet makes clear Radiogel is his lowest priority and hopless IsoPet is his highest priority. Again, gross incompetence on display.
Have no desire or objective to influence RDGL sp. Just objectively citing the facts per RDGL updates. But will note at low volume like today pps is meaningless.
Sad. Today MK releases a Tweet promoting himself and hopelessly unprofitable IsoPet. Radiogel is only thing that can save RDGL now, and it's clearly MK's lowest priority. Gross incompetence on display.
If you're in denial and calling the fact that Dr. Toskich is promoting a competitor's Y90 brachytherapy "bullshit", I can't help you. It's just a fact.
Who's talking crap on RDGL? A few of us just objectively cite the facts per RDGL own updates and financials. It's just a fact MK has been in charge for 8 years now, and here we are in 2024 with no end in sight getting Radiogel to human trials. It's just a fact MK failed to get Radiogel to market before the patents expired. Likeiwse it's just a fact that there is no plausible scenario for RDGL to get profitable via IsoPet. The only thing that can save RDGL now is getting Radiogel to human trials before the cash well runs dry. That makes everything else a distraction.
Facts are facts.
As far as pps, I've repeated said RDGL is fairly priced atm in the 5 cent range given risk and terms of last offering. Guy buying flea farts atm should get a discount vs. guy buy more than 4% of company from offering. The low average volume is far more concerning than pps at moment.
Didn't change subject. I'm sorry you don't understand the context of my response to another commenter condemning SS for trading a competitor's stock in addition to RDGL.
What does it matter? IsoPet is sold below cost. Given the low volume and RDGL overhead of a few million $, IsoPet wouldn't be profitable even if sold at 10X cost. But it's sold below cost. IsoPet is hopeless.
No. My comment was spot on regarding the context of another commenter condemning SS for trading a competitor's stock. Is he also likewise condemning Dr. Toskich? Point is neither SS or Dr. Toskich should be condemn for taking what they see as their best path at moment.
Right. But back to context of my comment, why condemn SS for commenting here while also going long or short with a competitor in addition to RDGL?
Dr. Toskich is doing what's in his and his patients' best interest while also allegedly consulting for RDGL. What's wrong with a trader/investor doing likewise?
It's been 5 years and all MK has proven is there's no profit in IsoPet. Only thing that can save RDGL now is getting Radiogel to human trials. Everything else is a distraction robbing from that objective. It is what it is.
Putting aside the 5 years MK wasted before talking to FDA about Radiogel human trials, it's been clear since 2021 that the IsoPet anecdotes are useless to FDA for considering Radiogel to human trials. FDA needs controlled and monitored animal data. To date MK has failed to deliver anything FDA suggested back in 2021.
Why? Because he's hopelessly distracted with hopelessly unprofitable IsoPet at expense of focusing on getting FDA what they need to consider Radiogel.
IsoPet was launched 5 years ago, has never made a profit, is currently sold below cost and revenues are declining.
The only thing that can save RDGL is getting Radiogel to human trials, and it's been clear for sometime that is MK's lowest priority. That's gross incompetence.
The potential gold mine upon positive human trial data, FDA approval, etc. for RDGL evaporated when MK failed to get Radiogel to market before the last of the original patents expired. It's still an FDA play, but a possible mega buyout price years from now is no longer in the cards. Radiogel is not cheap to make, has logistic challenges because Y90 has no shelf life and very limited pricing power given it's now public domain. It is what it is.
So what's your take on Dr. Toskich now promoting a different Y90 brachytherapy, not Radiogel? Do you condemn him for working with a competitor?
Yep, only source for this is from proven serial liar MK. There has been no corroboration from FDA.
Moreover, we now know since MK's Dec. 20, 2023 announcement, BDD status has no impact on getting Radiogel to human trials. MK still needs to deliver the data FDA suggested in 2021 they need to consider Radiogel for human trials, and to date, MK hasn't delivered a single item.
All facts.
"No pharma would ever set any dates until their testing was done."
Except MK already did that. He said RDGL would submit the IDE application no later than 90-120 days after May 24, 2021, a forecast he never withdrew. Here we are in 2024 and still no end in sight.
MK's intentional deceptions continue. In today's Tweet RDGL advertises a human treatment that doesn't exist yet (haven't even commenced Radiogel human trials, let alone been FDA approved for sale). He also claims the treatment is "patented", implying Radiogel treatment is under current patent protection. He intentionally deceives by neglecting to mention all the original patents have expired and all RDGL has is a single weak "improved" process patent for manufacturing Radiogel. The potential product and treatment method are both public domain now. Moreover there is no evidence the "improved" manufacturing process offers any performance advantages over the now public domain process.
All facts
In any executive summary, the most important item (aka top priority) is listed first. Least important item to the writer is listed last. Any RDGL update that doesn't lead with IDE is a down date.
Soon? When? There remains no timetable and update confirmed IDE is his lowest priority. Any update that doesn't lead with IDE is a down date.
MK has led RDGL for 8 years now. And here we are in March 2024 still without any idea when Radiogel will get to human trials. The update confirmed IDE remains his lowest priority. Hopeless IsoPet remains his highest priority. Moreover he failed to get Radiogel to market before the last of the original patents expired in 2022. Situation is what it is.
Nice to have an up day. But after today's late day turd drop confirming IDE remains lowest priority, is rally sustainable? Time will tell.
Yeah, always next month, quarter or year for RDGL. Been hearing that for years now.
Already commented regarding the Feb. down date. Any RDGL update not leading with IDE is a down date. Note here we are in March 2024. Down date confirms IDE remains MK's lowest priority and still no timetable to submission.
Feb. down date posted on Twitter. Confirms MK remains completely distracted with hopeless IsoPet and IDE submission remains his lowest priority (last item). It is what it is.
Sorry, a second horse experimentally treated with IsoPet for heel pain isn't going to save RDGL. The only thing that matters now is getting Radiogel to human trials, and that appears to be MK's lowest priority per his own updates. The guy is a gross incompetent.
Just citing the facts per RDGL's updates and financials. Facts are facts. What's your explanation for RDGL skimming a nickel now?
Ok, so MK repeatedly lied about submitting the IDE application in 2021, RDGL finances in 2022 and completing the rabbit testing in 2023, but we're to believe his claim of BDD status for Radiogel without any corroboration from a reputable source?
Again, even if he's telling truth about BDD status, we now know per his own updates, it's of no immediate consequence for getting Radiogel to human trials.
To close last offering after his BDD pump, he sold more than 4% of company in 6 cent range and had to renegotiate expiring warrants from previous offerings out to 2027. That says it all, and why pps has declined to a nickel since then.
Just citing the RDGL updates (their website and Twitter) and financials. It's all there for anyone who cares. MK has led RDGL for 8 years now and has been a disaster by any objective standard. He failed to get Radiogel to market before the last of the original patents expired in 2022. IsoPet is hopelessly unprofitable. Getting Radiogel to human trials is his lowest priority. It is what it is.
There's been no corroboration of serial liar MK's claim of BDD status for Radiogel. The market doesn't believe it, or doesn't believe it's of any immediate consequence. But even if he's telling the truth about BDD status, we already know per his own updates since then, it has no impact on getting Radiogel to human trials. RDGL still has to submit an IDE application for human trials. Then FDA has 30 days to consider the application and can either approve human trials, conditionally approve with a list of issues that must be resolved before human trials commence or reject the application.
The stock is fairly priced now given the last offering in the 6 cent range for over 4% of company after the BDD pump. So only fair someone buying flea farts of company atm should pay in the 5 cent range. Keep in mind that MK has been at helm of RDGL for 8 years now, and there's still no end in sight to getting Radiogel to human trials. Instead he remains hopelessly distracted with $ losing IsoPet.
Look at stock chart. Market says otherwise.